FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy
Work
Year: 2024
Type: article
Abstract: Chimeric antigen receptor (CAR) T cell therapy has transformed the treatment of haematological malignancies such as acute lymphoblastic leukaemia, B cell lymphoma and multiple myeloma 1–4 , but the e... more
Source: Nature
Institutions Peter MacCallum Cancer Centre, RMIT University, The University of Melbourne, Olivia Newton-John Cancer Wellness & Research Centre, La Trobe University
Cites: 65
Cited by: 64
Related to: 10
FWCI: 55.06
Citation percentile (by year/subfield): 100
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: hybrid
APC paid (est): $11,690